Trust Company’s AstraZeneca AZN Stock Holding History

Trust Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$948	Hold	5	–	–	﹤0.01%	614
2026 Q1	$986	Hold	5	–	–	﹤0.01%	578
2025 Q4	$919	Buy	+5	New	+$877	﹤0.01%	574
2017 Q4	–	Sell	-200	Closed	-$14K	–	373
2017 Q3	$14K	Hold	200	–	–	0.01%	227
2017 Q2	$14K	Sell	200 -75	-27%	-$4.9K	0.01%	237
2017 Q1	$17K	Hold	275	–	–	0.01%	250
2016 Q4	$15K	Hold	275	–	–	0.01%	258
2016 Q3	$18K	Hold	275	–	–	0.01%	248
2016 Q2	$17K	Hold	275	–	–	0.01%	244
2016 Q1	$15K	Sell	275 -30	-10%	-$1.8K	0.01%	248
2015 Q4	$20.7K	Sell	305 -135	-31%	-$8.85K	0.01%	229
2015 Q3	$28K	Buy	440 +240	+120%	+$15.8K	0.02%	211
2015 Q2	$13K	Hold	200	–	–	0.01%	273
2015 Q1	$14K	Buy	+200	New	+$13.9K	0.01%	225

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Trust Company's AZN Position: Q2 2026 in Review

Trust Company held its AstraZeneca (AZN) position steady in Q2 2026 at 5 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #614.

Trust Company first reported a position in AZN in Q1 2015 and has held it in 14 quarters since. The position peaked at $28K in Q3 2015. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Trust Company held 5 shares of AstraZeneca worth $948 as of Q2 2026.
Trust Company left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #614 holding.
Trust Company first reported a position in AstraZeneca in Q1 2015 and has held it in 14 quarters since.
Trust Company's AstraZeneca position peaked at $28K in Q3 2015.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.